Epidemiology of invasive group A Streptococcus disease in the United States, 1995-1999

被引:279
作者
O'Brien, KL
Beall, B
Barrett, NL
Cieslak, PR
Reingold, A
Farley, MM
Danila, R
Zell, ER
Facklam, R
Schwartz, B
Schuchat, A
机构
[1] CDCP, Natl Ctr Infect Dis, Resp Dis Branch, Div Bacterial & Mycot Dis, Atlanta, GA USA
[2] CDCP, Natl Ctr Infect Dis, Biostat & Informat Management Branch, Div Bacterial & Mycot Dis, Atlanta, GA USA
[3] Emory Univ, Sch Med, Emerging Infect Program, Georgia Dept Human Resources, Atlanta, GA 30322 USA
[4] Atlanta VA Med Ctr, Atlanta, GA USA
[5] Connecticut Dept Publ Hlth, Emerging Infect Program, Hartford, CT USA
[6] Oregon Dept Human Resources, Hlth Div, Emerging Infect Programs, Portland, OR USA
[7] Univ Calif Berkeley, Sch Publ Hlth, Berkeley, CA 94720 USA
[8] Univ Calif Berkeley, Calif Emerging Infect Program, Berkeley, CA 94720 USA
[9] Minnesota Dept Hlth, Emerging Infect Program, Minneapolis, MN USA
关键词
D O I
10.1086/341409
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Severe invasive group A streptococcal (GAS) disease is believed to have reemerged during the past 10-20 years. We conducted active, laboratory, population-based surveillance in 5 US states (total population, 13,214,992). From 1 July 1995 through 31 December 1999, we identified 2002 episodes of invasive GAS (3.5 cases per 100,000 persons). Rates varied by age (higher among those <2 or >= 65 years old), surveillance area, and race (higher among black individuals) but did not increase during the study period. The 5 most common emm types (1, 28, 12, 3, and 11) accounted for 49.2% of isolates; newly characterized emm types accounted for 8.9% of isolates. Older age; presence of streptococcal toxic shock syndrome, meningitis, or pneumonia; and infection with emm1 or emm3 were all independent predictors of death. We estimate that 9600-9700 cases of invasive GAS disease occur in the United States each year, resulting in 1100-1300 deaths.
引用
收藏
页码:268 / 276
页数:9
相关论文
共 58 条
  • [1] OUTBREAK OF INVASIVE GROUP-A STREPTOCOCCAL INFECTIONS IN A NURSING-HOME - LESSONS ON PREVENTION AND CONTROL
    AUERBACH, SB
    SCHWARTZ, B
    WILLIAMS, D
    FIORILLI, MG
    ADIMORA, AA
    BREIMAN, RF
    JARVIS, WR
    [J]. ARCHIVES OF INTERNAL MEDICINE, 1992, 152 (05) : 1017 - 1022
  • [2] PNEUMONIA IN CHILDREN IN THE EASTERN HIGHLANDS OF PAPUA-NEW-GUINEA - A BACTERIOLOGIC STUDY OF PATIENTS SELECTED BY STANDARD CLINICAL-CRITERIA
    BARKER, J
    GRATTEN, M
    RILEY, I
    LEHMANN, D
    MONTGOMERY, J
    KAJOI, M
    GRATTEN, H
    SMITH, D
    MARSHALL, TFD
    ALPERS, MP
    [J]. JOURNAL OF INFECTIOUS DISEASES, 1989, 159 (02) : 348 - 352
  • [3] Streptococcal emm types associated with T-agglutination types and the use of conserved emm gene restriction fragment patterns for subtyping group A streptococci
    Beall, B
    Facklam, RR
    Elliott, JA
    Franklin, AR
    Hoenes, T
    Jackson, D
    Laclaire, L
    Thompson, T
    Viswanathan, R
    [J]. JOURNAL OF MEDICAL MICROBIOLOGY, 1998, 47 (10) : 893 - 898
  • [4] Survey of emm gene sequences and T-antigen types from systemic Streptococcus pyogenes infection isolates collected in San Francisco, California; Atlanta, Georgia; and Connecticut in 1994 and 1995
    Beall, B
    Facklam, R
    Hoenes, T
    Schwartz, B
    [J]. JOURNAL OF CLINICAL MICROBIOLOGY, 1997, 35 (05) : 1231 - 1235
  • [5] Sequencing emm-specific PCR products for routine and accurate typing of group a streptococci
    Beall, B
    Facklam, R
    Thompson, T
    [J]. JOURNAL OF CLINICAL MICROBIOLOGY, 1996, 34 (04) : 953 - 958
  • [6] emm and sof gene sequence variation in relation to serological typing of opacity-factor-positive group A streptococci
    Beall, B
    Gherardi, G
    Lovgren, M
    Facklam, RR
    Forwick, BA
    Tyrrell, GJ
    [J]. MICROBIOLOGY-SGM, 2000, 146 : 1195 - 1209
  • [7] New multi-determinant strategy for a group A streptococcal vaccine designed for the Australian Aboriginal population
    Brandt, ER
    Sriprakash, KS
    Hobb, RI
    Hayman, WA
    Zeng, WG
    Batzloff, MR
    Jackson, DC
    Good, MF
    [J]. NATURE MEDICINE, 2000, 6 (04) : 455 - 459
  • [8] DEFINING THE GROUP-A STREPTOCOCCAL TOXIC SHOCK SYNDROME - RATIONALE AND CONSENSUS DEFINITION
    BREIMAN, RF
    DAVIS, JP
    FACKLAM, RR
    GRAY, BM
    HOGE, CW
    KAPLAN, EL
    MORTIMER, EA
    SCHLIEVERT, PM
    SCHWARTZ, B
    STEVENS, DL
    TODD, JK
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1993, 269 (03): : 390 - 391
  • [9] Centers for Disease Control (CDC), 1988, MMWR Morb Mortal Wkly Rep, V37, P519
  • [10] Antibody against surface-bound C5a peptidase is opsonic and initiates macrophage killing of group B streptococci
    Cheng, Q
    Carlson, B
    Pillai, S
    Eby, R
    Edwards, L
    Olmsted, SB
    Cleary, P
    [J]. INFECTION AND IMMUNITY, 2001, 69 (04) : 2302 - 2308